CN Patent

CN101065360A — Bay43－9006甲苯磺酸盐的热力学稳定形式

Assigned to Bayer Pharma AG · Expires 2007-10-31 · 19y expired

What this patent protects

本发明涉及新型、室温下热力学稳定的4－{4－[({[4－氯－3－(三氟甲基)苯基]氨基}羰基)氨基]苯氧基}－N－甲基吡啶－2－甲酰胺的甲苯磺酸盐，其制备方法，包含它的药物及其在控制病症中的用途。

USPTO Abstract

本发明涉及新型、室温下热力学稳定的4－{4－[({[4－氯－3－(三氟甲基)苯基]氨基}羰基)氨基]苯氧基}－N－甲基吡啶－2－甲酰胺的甲苯磺酸盐，其制备方法，包含它的药物及其在控制病症中的用途。

Drugs covered by this patent

sorafenib-tosylate (SORAFENIB TOSYLATE)

Patent Metadata

Patent number: CN101065360A
Jurisdiction: CN
Classification: —
Expires: 2007-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Pharma AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.